This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
EastGroup Properties (EGP)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
EGPNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Baxter Q3 Preview: Can Core Segments Deliver Another Solid Quarter?
by Zacks Equity Research
Baxter's Q3 results are expected to show steady revenue growth led by Advanced Surgery and Drug Compounding, though IV fluid and anesthesia softness may weigh on EPS.
BAXPositive Net Change MCKNegative Net Change CORNegative Net Change GMEDNegative Net Change
medical medical-devices
Is CVS Health's Pharmacy & Consumer Wellness Poised for a Stronger Q3?
by Moumi Mondal
CVS' Pharmacy & Consumer Wellness arm gains traction from tech upgrades, new Rite Aid assets and its evolving CostVantage model.
AMZNNegative Net Change WMTPositive Net Change CVSNegative Net Change
medical medical-devices
HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now?
by Zacks Equity Research
Hims & Hers and LifeMD are reshaping virtual care, but which one leads in earnings growth and platform scale? Let's dive in.
HIMSPositive Net Change LFMDPositive Net Change
medical medical-devices
Do Options Traders Know Something About ResMed Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to RMD stock based on the movements in the options market lately.
RMDPositive Net Change
medical medical-devices
RVTY Q3 Earnings Beat, Sales In Line, '25 EPS View Raised
by Zacks Equity Research
Revvity beats on Q3 earnings and raises 2025 EPS view, as balanced segment performance offsets margin pressure.
BSXNegative Net Change HQYNegative Net Change RVTYPositive Net Change SOLVNegative Net Change
earnings medical medical-devices
Best Momentum Stock to Buy for Oct. 27th
by Zacks Equity Research
PRM, GM and ISRG made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 27, 2025.
ISRGPositive Net Change GMPositive Net Change PRMPositive Net Change
auto-tires-trucks medical-devices
Does GEHC Stock Deserve a Spot in Your Portfolio Ahead of Q3 Earnings?
by Zacks Equity Research
GE HealthCare's Q3 results are expected to show steady growth from Imaging and Diagnostics, though tariffs may weigh on margins and EPS.
BSXNegative Net Change ZBHNegative Net Change GEHCPositive Net Change SOLVNegative Net Change
medical medical-devices
CVS vs. FMS: Which Healthcare Services Stock Has More Upside?
by Moumi Mondal
CVS outpaces FMS in share gains and valuation appeal, with stronger earnings momentum and expanding health services driving its edge.
CVSNegative Net Change FMSNegative Net Change
medical medical-devices
ITGR Shares Down Despite Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Integer Holdings posts strong Q3 results with earnings and revenue beat, but shares plunge on a softer 2026 growth outlook.
PODDNegative Net Change PAHCPositive Net Change VCYTPositive Net Change ITGRNegative Net Change
earnings medical medical-devices
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now
by Zacks Equity Research
FMS acquisitions, partnerships and global reach fuel growth, though rising costs weigh on near-term prospects.
MASINegative Net Change FMSNegative Net Change MMSINegative Net Change WSTPositive Net Change
medical medical-devices
Zacks Investment Ideas feature highlights: Intuitive Surgical's
by Zacks Equity Research
Intuitive Surgical surges after a strong Q3 beat, lifted by soaring da Vinci procedure volumes and raised full-year guidance.
ISRGPositive Net Change
medical-devices
After Golden Cross, Aaon (AAON)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
AAONNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Will SYK's Q3 Results Reflect MedSurg Strength & Rebound in Orthopaedics?
by Zacks Equity Research
Stryker's Q3 results are expected to highlight MedSurg strength and solid robotics-led growth in Orthopaedics, partly offset by tariff headwinds.
SYKNegative Net Change MCKNegative Net Change EWNegative Net Change GMEDNegative Net Change
medical medical-devices
Pharma, Specialty Units Likely to Drive Cardinal Health's Q1 Earnings
by Zacks Equity Research
CAH's Pharmaceutical and Specialty units are expected to have fueled double-digit revenue growth in Q1 FY26 despite tariff and cost headwinds.
BDXPositive Net Change CAHNegative Net Change MCKNegative Net Change CORNegative Net Change
medical medical-devices
Here's How Charles River Stock Is Placed Ahead of Q3 Earnings
by Zacks Equity Research
CRL heads into Q3 earnings with steady RMS growth but faces DSA headwinds from tight biotech budgets.
CRLPositive Net Change ANIPPositive Net Change EXASPositive Net Change EHCNegative Net Change
earnings medical medical-devices
Buy the Post-Earnings Surge in Intuitive Surgical (ISRG) Stock?
by Shaun Pruitt
Intuitive Surgical's stock has been on a tear since the medical pioneer exceeded Q3 expectations on Tuesday and provided positive guidance that left investors hyped about rising demand for robotic-assisted surgical systems.
ISRGPositive Net Change
earnings investing large-cap medical medical-devices robotics
Here's Why You Should Add OPKO Health Stock to Your Portfolio
by Zacks Equity Research
OPK benefits from RAYALDEE momentum, strategic deals and advancing trials amid stiff competition and dependence risks.
MASINegative Net Change MMSINegative Net Change WSTPositive Net Change OPKPositive Net Change
medical medical-devices
Can Sustained Strength in Water Drive ECL Stock Before Q3 Earnings?
by Zacks Equity Research
Ecolab's Water and Pest units show strength ahead of third-quarter 2025, but softness in Paper and macroeconomic headwinds may weigh on growth.
ECLNegative Net Change ESIPositive Net Change COIHYPositive Net Change SYIEYNegative Net Change
earnings medical medical-devices
WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit
by Zacks Equity Research
West Pharmaceutical's strong Q3 beat and raised EPS outlook highlight robust demand, FX tailwinds, and solid growth in Proprietary Products.
BSXNegative Net Change MASINegative Net Change MMSINegative Net Change WSTPositive Net Change
earnings medical medical-devices
Zacks.com featured highlights include The Honest Company, Dutch, AIM ImmunoTech, Masimo and Cognizant Technology Solutions
by Zacks Equity Research
HNST, BROS, AIM, MASI, and CTSH are spotlighted as top-ranked stocks with rising P/E ratios and strong earnings momentum.
CTSHPositive Net Change MASINegative Net Change AIMPositive Net Change HNSTPositive Net Change BROSPositive Net Change
computers consumer-discretionary medical medical-devices restaurants
Here's How Henry Schein Is Placed Ahead of Q3 Earnings
by Zacks Equity Research
HSIC heads into Q3 with solid gains expected across Dental, Specialty and Tech segments, though earnings estimates have slipped slightly.
HSICPositive Net Change ANIPPositive Net Change EXASPositive Net Change EHCNegative Net Change
earnings medical medical-devices
Will RVTY Q3 Earnings Reflect Segmental Strength Amid Rising Demand?
by Zacks Equity Research
RVTY's third-quarter results are likely to reflect strong performance in the Life Sciences segment. However, the Diagnostic segment is set to face challenges in China.
MCKNegative Net Change EWNegative Net Change GMEDNegative Net Change RVTYPositive Net Change
medical medical-devices
GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring
by Zacks Equity Research
GE HealthCare secures CE mark for Carevance, advancing scalable, cost-effective monitoring across care settings.
BSXNegative Net Change RMDPositive Net Change MASINegative Net Change GEHCPositive Net Change
medical medical-devices
ISRG Stock Gains on Q3 Earnings & Revenue Beat, Gross Margin Declines
by Zacks Equity Research
Intuitive Surgical's shares jump 17% after Q3 earnings and revenues beat expectations, fueled by surging da Vinci 5 placements and strong global procedure growth.
ISRGPositive Net Change PODDNegative Net Change PAHCPositive Net Change VCYTPositive Net Change
earnings medical medical-devices